TRIB
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
35.06M
GET INTRADAY SIGNALS
TRIB Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
One day until earnings call
+Compare
TRIB
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
35.06M

TRIB Price Prediction, Trinity Biotech plc AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
TRIB Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Mar 21, 2023

Momentum Indicator for TRIB turns negative, indicating new downward trend

TRIB saw its Momentum Indicator move below the 0 level on February 27, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In 86 of the 92 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TRIB turned negative on February 27, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

TRIB moved below its 50-day moving average on February 27, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TRIB crossed bearishly below the 50-day moving average on March 07, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TRIB's RSI Indicator exited the oversold zone, of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where TRIB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRIB advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

TRIB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 128 cases where TRIB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.285) is normal, around the industry mean (16.421). P/E Ratio (33.003) is within average values for comparable stocks, (183.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.837). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.412) is also within normal values, averaging (56.524).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRIB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

AI
A.I. Advisor
published Earnings

TRIB is expected to report earnings to fall 74.44% to -5 cents per share on March 23

Trinity Biotech plc TRIB Stock Earnings Reports
Q4'22
Est.
$-0.06
Q3'22
Missed
by $0.19
Q2'22
Missed
by $0.26
Q1'22
Missed
by $0.04
Q4'21
Missed
by $0.01
The last earnings report on December 15 showed earnings per share of -23 cents, missing the estimate of -3 cents. With 13.75K shares outstanding, the current market capitalization sits at 35.06M.
AI
A.I.Advisor
published Dividends

TRIB paid dividends on July 01, 2015

Trinity Biotech plc TRIB Stock Dividends
А dividend of $0.22 per share was paid with a record date of July 01, 2015, and an ex-dividend date of June 05, 2015. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.27B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 0%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was 9%. TPGVF experienced the highest price growth at 121%, while AZYO experienced the biggest fall at -71%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was -8% and the average quarterly volume growth was -88%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 56
SMR Rating: 82
Profit Risk Rating: 85
Seasonality Score: 4 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published General Information

General Information

a devloper of medical diagnostic products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
IDA Business Park
Phone
+353 12769800
Employees
477
Web
https://www.trinitybiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPOP54.302.07
+3.96%
Popular
MEIP0.250.01
+3.90%
MEI Pharma
SBR69.742.09
+3.09%
Sabine Royalty Trust
IDXX495.4012.14
+2.51%
IDEXX Laboratories
ALT4.95-5.97
-54.67%
Altimmune

TRIB and

Correlation & Price change

A.I.dvisor tells us that TRIB and BRKR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and BRKR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
+0.01%
BRKR - TRIB
32%
Poorly correlated
+1.62%
A - TRIB
32%
Poorly correlated
+1.84%
MTD - TRIB
31%
Poorly correlated
+1.73%
CSTL - TRIB
30%
Poorly correlated
+4.97%
RGEN - TRIB
30%
Poorly correlated
+1.00%
More